NMRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,407,295.60

Neumora Therapeutics Insider Trading History Chart

Neumora Therapeutics Share Price & Price History

^$0.78

▲ +0.0128 (1.67%)

As of 04/30/2025 05:00 PM ET

Days: 30 | 90 | 365

Neumora Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/18/2025	Joshua Pinto	President	Sell	8,048	$1.67	$13,440.16	76,952
2/18/2025	Michael Lee Milligan	Insider	Sell	1,978	$1.69	$3,342.82	22,470
10/18/2024	Matthew K Fust	Director	Sell	14,049	$17.03	$239,254.47	20,100
10/9/2024	Robert A Lenz	Insider	Sell	5,563	$15.01	$83,500.63	322,966
9/17/2024	Robert A Lenz	Insider	Sell	30,788	$11.81	$363,606.28	339,205
8/26/2024	Joshua Pinto	CFO	Sell	31,642	$11.78	$372,742.76	154,658
8/22/2024	Joshua Pinto	CFO	Sell	28,496	$11.63	$331,408.48	210,469
11/14/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	3,357	$11.98	$40,216.86	4,131,207
11/13/2023	Kristina Burow	Director	Buy	31,653	$11.75	$371,922.75	4,127,850
11/10/2023	Kristina Burow	Director	Buy	17,275	$11.49	$198,489.75	4,096,197
11/9/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	31,079	$10.53	$327,261.87	4,078,922
11/8/2023	Kristina Burow	Director	Buy	92,251	$11.03	$1,017,528.53	4,047,843
11/7/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	30,192	$11.50	$347,208.00	3,955,592
11/6/2023	Kristina Burow	Director	Buy	43,082	$11.55	$497,597.10	3,925,400
11/3/2023	Kristina Burow	Director	Buy	22,420	$11.38	$255,139.60	3,882,318
9/29/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	34,560	$13.98	$483,148.80	3,859,898
9/28/2023	Kristina Burow	Director	Buy	41,951	$13.44	$563,821.44	3,825,338
9/27/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	24,504	$12.31	$301,644.24	3,783,387
9/26/2023	Kristina Burow	Director	Buy	34,000	$11.73	$398,820.00	3,758,883
9/25/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	60,740	$11.22	$681,502.80	3,724,883
9/22/2023	Arch Venture Partners Xii, Llc	Major Shareholder	Buy	40,000	$11.14	$445,600.00	3,664,143
9/19/2023	Amgen Inc	Major Shareholder	Buy	1,764,705	$17.00	$29,999,985.00	35,368,653
9/19/2023	Henry O Gosebruch	CEO	Buy	15,000	$12.62	$189,300.00	15,000
9/19/2023	Kristina Burow	Director	Buy	1,500,000	$17.00	$25,500,000.00	3,624,143

See Full Table

SEC Filings (Institutional Ownership Changes) for Neumora Therapeutics (NASDAQ:NMRA)

47.65% of Neumora Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neumora Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/30/2025	Cerity Partners LLC	302,505	$0.30M	0.0%	+24.0%	0.187%
4/30/2025	Alps Advisors Inc.	114,371	$0.11M	0.0%	-12.5%	0.071%
4/25/2025	Lunate Capital Ltd	2,124,143	$2.12M	1.2%	N/A	1.313%
3/18/2025	California State Teachers Retirement System	54,457	$0.58M	0.0%	+793.5%	0.034%
2/26/2025	Windmill Hill Asset Management Ltd	104,373	$1.11M	0.4%	+299.6%	0.065%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	72,622	$0.77M	0.0%	N/A	0.045%
2/17/2025	Wexford Capital LP	252,122	$2.67M	0.4%	+15.7%	0.156%
2/17/2025	Toronto Dominion Bank	34,300	$0.36M	0.0%	N/A	0.021%
2/17/2025	Stempoint Capital LP	428,137	$4.54M	1.1%	N/A	0.265%
2/17/2025	Softbank Group CORP.	6,541,190	$69.34M	0.3%	-13.3%	4.049%
2/17/2025	Rafferty Asset Management LLC	17,431	$0.19M	0.0%	N/A	0.011%
2/17/2025	Numerai GP LLC	51,696	$0.55M	0.2%	+46.7%	0.032%
2/17/2025	Orbimed Advisors LLC	804,996	$8.53M	0.2%	-46.3%	0.498%
2/17/2025	Janus Henderson Group PLC	26,500	$0.28M	0.0%	N/A	0.016%
2/17/2025	Graham Capital Management L.P.	66,669	$0.71M	0.0%	N/A	0.041%
2/17/2025	Deutsche Bank AG	73,103	$0.78M	0.0%	+50.4%	0.045%
2/17/2025	Cutter Capital Management LP	150,000	$1.59M	0.7%	N/A	0.093%
2/17/2025	Brevan Howard Capital Management LP	80,559	$0.85M	0.0%	N/A	0.050%
2/17/2025	BNP Paribas Financial Markets	20,885	$0.22M	0.0%	N/A	0.013%
2/17/2025	Ameriprise Financial Inc.	118,674	$1.26M	0.0%	N/A	0.073%
2/14/2025	PDT Partners LLC	25,023	$0.27M	0.0%	-20.1%	0.015%
2/14/2025	Schonfeld Strategic Advisors LLC	521,013	$5.52M	0.0%	+273.9%	0.322%
2/14/2025	Northern Trust Corp	734,847	$7.79M	0.0%	+7.7%	0.455%
2/14/2025	The Manufacturers Life Insurance Company	45,060	$0.48M	0.0%	-59.0%	0.028%
2/14/2025	T. Rowe Price Investment Management Inc.	5,002,799	$53.03M	0.0%	-4.3%	3.097%
2/14/2025	Price T Rowe Associates Inc. MD	32,548	$0.35M	0.0%	-94.8%	0.020%
2/14/2025	Soros Capital Management LLC	279,333	$2.96M	0.5%	-45.1%	0.173%
2/14/2025	Rock Springs Capital Management LP	955,106	$10.12M	0.4%	+15.3%	0.591%
2/14/2025	Capital International Investors	3,700,359	$39.22M	0.0%	+692.1%	2.290%
2/13/2025	PEAK6 LLC	11,057	$0.12M	0.0%	N/A	0.007%
2/13/2025	XTX Topco Ltd	21,838	$0.23M	0.0%	N/A	0.014%
2/13/2025	Barclays PLC	166,822	$1.77M	0.0%	+29.1%	0.103%
2/13/2025	Legal & General Group Plc	59,842	$0.63M	0.0%	+526.4%	0.037%
2/13/2025	Invesco Ltd.	49,249	$0.52M	0.0%	+254.1%	0.030%
2/13/2025	ADAR1 Capital Management LLC	68,608	$0.73M	0.1%	N/A	0.042%
2/13/2025	Wells Fargo & Company MN	70,653	$0.75M	0.0%	+23.0%	0.044%
2/12/2025	Geode Capital Management LLC	1,970,280	$20.89M	0.0%	-0.5%	1.220%
2/12/2025	Franklin Resources Inc.	31,357	$0.33M	0.0%	-58.6%	0.019%
2/12/2025	Alliancebernstein L.P.	199,947	$2.12M	0.0%	-10.3%	0.124%
2/12/2025	Norges Bank	110,000	$1.17M	0.0%	N/A	0.068%
2/11/2025	EntryPoint Capital LLC	12,762	$0.14M	0.1%	N/A	0.008%
2/11/2025	Vanguard Group Inc.	4,572,308	$48.47M	0.0%	+4.5%	2.830%
2/11/2025	KLP Kapitalforvaltning AS	13,500	$0.14M	0.0%	N/A	0.008%
2/11/2025	Quantbot Technologies LP	8,646	$92K	0.0%	N/A	0.005%
2/11/2025	Teacher Retirement System of Texas	16,669	$0.18M	0.0%	N/A	0.010%
2/10/2025	Swiss National Bank	110,200	$1.17M	0.0%	N/A	0.068%
2/7/2025	PNC Financial Services Group Inc.	6,000	$64K	0.0%	N/A	0.004%
2/7/2025	AMG National Trust Bank	43,379	$0.48M	0.0%	N/A	0.027%
2/7/2025	Candriam S.C.A.	571,027	$6.05M	0.0%	-15.6%	0.353%
2/6/2025	Arizona State Retirement System	16,222	$0.17M	0.0%	N/A	0.010%
2/6/2025	Charles Schwab Investment Management Inc.	704,154	$7.46M	0.0%	+0.8%	0.436%
2/3/2025	Callan Capital LLC	636,194	$6.74M	0.5%	-3.8%	0.394%
2/3/2025	Ieq Capital LLC	36,853	$0.39M	0.0%	-50.8%	0.023%
1/31/2025	Addis & Hill Inc	163,386	$1.73M	1.3%	-45.5%	0.101%
1/28/2025	Windmill Hill Asset Management Ltd	104,373	$1.11M	1.1%	+299.6%	0.065%
1/27/2025	Mirae Asset Global Investments Co. Ltd.	5,384	$61K	0.0%	N/A	0.003%
1/24/2025	SkyOak Wealth LLC	20,000	$0.21M	0.0%	+33.3%	0.012%
1/24/2025	China Universal Asset Management Co. Ltd.	34,257	$0.36M	0.0%	N/A	0.021%
1/17/2025	SG Americas Securities LLC	14,119	$0.15M	0.0%	-34.6%	0.009%
12/26/2024	JPMorgan Chase & Co.	64,421	$0.85M	0.0%	+2.6%	0.040%
11/27/2024	Franklin Resources Inc.	75,702	$1M	0.0%	-13.9%	0.047%
11/19/2024	Barclays PLC	129,210	$1.71M	0.0%	+352.9%	0.080%
11/16/2024	Geode Capital Management LLC	1,979,847	$26.16M	0.0%	+54.0%	1.225%
11/15/2024	Barclays PLC	129,210	$1.71M	0.0%	+352.9%	0.080%
11/15/2024	Wexford Capital LP	217,879	$2.88M	0.7%	+90.1%	0.135%
11/15/2024	State Street Corp	1,790,707	$23.66M	0.0%	+65.3%	1.108%
11/15/2024	Quarry LP	5,000	$66K	0.0%	-50.0%	0.003%
11/15/2024	Point72 Asset Management L.P.	83,077	$1.10M	0.0%	N/A	0.051%
11/13/2024	FMR LLC	7,749,156	$102.37M	0.0%	-10.1%	4.842%
11/13/2024	The Manufacturers Life Insurance Company	109,802	$1.45M	0.0%	-1.8%	0.069%
11/12/2024	Cerity Partners LLC	242,900	$3.21M	0.0%	N/A	0.152%
11/12/2024	Charles Schwab Investment Management Inc.	698,255	$9.22M	0.0%	+139.7%	0.436%
11/9/2024	Intech Investment Management LLC	13,275	$0.18M	0.0%	N/A	0.008%
10/30/2024	Auour Investments LLC	250,000	$3.30M	1.2%	N/A	0.156%
10/23/2024	Ballentine Partners LLC	13,441	$0.18M	0.0%	N/A	0.008%
10/9/2024	Clarius Group LLC	16,992	$0.22M	0.0%	N/A	0.011%
10/5/2024	Handelsbanken Fonder AB	26,600	$0.35M	0.0%	+35.0%	0.017%
10/3/2024	SG Americas Securities LLC	21,581	$0.29M	0.0%	-62.5%	0.014%
8/27/2024	Logos Global Management LP	300,000	$2.95M	0.2%	-21.5%	0.188%
8/16/2024	Quarry LP	10,000	$98K	0.0%	N/A	0.006%
8/15/2024	The Manufacturers Life Insurance Company	111,828	$1.10M	0.0%	+79.5%	0.070%
8/14/2024	Marshall Wace LLP	134,545	$1.32M	0.0%	N/A	0.084%
8/14/2024	Logos Global Management LP	300,000	$2.95M	0.2%	-21.5%	0.188%
8/13/2024	Callan Capital LLC	661,194	$6.50M	0.5%	+222.6%	0.414%
8/12/2024	SkyOak Wealth LLC	15,000	$0.15M	0.0%	N/A	0.009%
8/12/2024	Amalgamated Bank	2,910	$29K	0.0%	+472.8%	0.002%
8/3/2024	TD Asset Management Inc	144,994	$1.43M	0.0%	+31.6%	0.091%
8/1/2024	Rhumbline Advisers	103,258	$1.02M	0.0%	+488.3%	0.065%
7/29/2024	Principal Financial Group Inc.	16,878	$0.17M	0.0%	N/A	0.011%
7/26/2024	Bank of New York Mellon Corp	235,593	$2.32M	0.0%	+474.1%	0.148%
7/12/2024	SG Americas Securities LLC	57,607	$0.57M	0.0%	N/A	0.036%
5/17/2024	Artal Group S.A.	2,924,052	$40.21M	1.0%	+14.5%	1.833%
5/16/2024	Kennedy Capital Management LLC	136,828	$1.88M	0.0%	N/A	0.086%
5/15/2024	Baker BROS. Advisors LP	633,851	$8.72M	0.1%	N/A	0.397%
5/15/2024	Price T Rowe Associates Inc. MD	752,924	$10.35M	0.0%	N/A	0.472%
5/14/2024	Nan Fung Group Holdings Ltd	63,315	$0.87M	0.8%	N/A	0.040%
5/10/2024	Vanguard Group Inc.	334,330	$4.60M	0.0%	-12.2%	0.210%
5/3/2024	Callan Capital LLC	204,987	$2.82M	0.2%	N/A	0.129%
5/1/2024	Auour Investments LLC	105,087	$1.45M	0.5%	N/A	0.066%
4/23/2024	Addis & Hill Inc	314,821	$4.19M	3.6%	N/A	0.198%

Data available starting January 2016

See Full Table

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $0.78

$0.73

$0.78

50 Day Range

MA: $1.05

$0.63

$1.71

52 Week Range

Now: $0.78

$0.62

$17.19

Volume

804,157 shs

Average Volume

1,485,671 shs

Market Capitalization

$126.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.89

Who are the company insiders with the largest holdings of Neumora Therapeutics?: Neumora Therapeutics' top insider shareholders include:
Amgen Inc (Major Shareholder)
Arch Venture Partners Xii, Llc (Major Shareholder)
Kristina Burow (Director)
Robert A Lenz (Insider)
Joshua Pinto (CFO)
Joshua Pinto (President)
Michael Lee Milligan (Insider)
Matthew K Fust (Director)
Henry O Gosebruch (CEO)
Learn More about top insider investors at Neumora Therapeutics.
Who are the major institutional investors of Neumora Therapeutics?: Neumora Therapeutics' top institutional investors include:
Lunate Capital Ltd — 1.31%
Cerity Partners LLC — 0.19%
Alps Advisors Inc. — 0.07%
Learn More about top institutional investors of Neumora Therapeutics stock.
Which institutional investors are selling Neumora Therapeutics stock?: In the last quarter, NMRA stock was sold by these institutional investors:
Alps Advisors Inc.
During the previous year, company insiders that have sold Neumora Therapeutics company stock include:
Amgen Inc (Major Shareholder)
Arch Venture Partners Xii, Llc (Major Shareholder)
Kristina Burow (Director)
Robert A Lenz (Insider)
Joshua Pinto (CFO)
Learn More investors selling Neumora Therapeutics stock.
Which institutional investors are buying Neumora Therapeutics stock?: Within the previous quarter, NMRA stock was purchased by institutional investors including:
Lunate Capital Ltd
Cerity Partners LLC
Within the previous year, these company insiders have bought Neumora Therapeutics stock:
Amgen Inc (Major Shareholder)
Arch Venture Partners Xii, Llc (Major Shareholder)
Kristina Burow (Director)
Robert A Lenz (Insider)
Learn More investors buying Neumora Therapeutics stock.